286 related articles for article (PubMed ID: 24007552)
1. Prevalence of specific anti-skin autoantibodies in a cohort of patients with inherited epidermolysis bullosa.
Tampoia M; Bonamonte D; Filoni A; Garofalo L; Morgese MG; Brunetti L; Di Giorgio C; Annicchiarico G
Orphanet J Rare Dis; 2013 Sep; 8():132. PubMed ID: 24007552
[TBL] [Abstract][Full Text] [Related]
2. Patients suffering from dystrophic epidermolysis bullosa are prone to developing autoantibodies against skin proteins: A longitudinal confirmational study.
Bremer J; Pas HH; Diercks GFH; Meijer HJ; van der Molen SM; Nijenhuis AM; van Nijen-Vos LL; Morandé P; Yubero MJ; Palisson F; Fuentes I; Pasmooij AMG
Exp Dermatol; 2024 Feb; 33(2):e15035. PubMed ID: 38389191
[TBL] [Abstract][Full Text] [Related]
3. Autoimmunity and Cytokine Imbalance in Inherited Epidermolysis Bullosa.
Esposito S; Guez S; Orenti A; Tadini G; Scuvera G; Corti L; Scala A; Biganzoli E; Berti E; Principi N
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669234
[TBL] [Abstract][Full Text] [Related]
4. Epidermolysis Bullosa (EB) Acquisita in an Adult Patient with Previously Unrecognized Mild Dystrophic EB and Biallelic COL7A1 Mutations.
Guerra L; Condorelli AG; Fortugno P; Calabresi V; Pedicelli C; Di Zenzo G; Castiglia D
Acta Derm Venereol; 2018 Apr; 98(4):411-415. PubMed ID: 29182795
[TBL] [Abstract][Full Text] [Related]
5. Occurrence of autoantibodies against skin proteins in patients with hereditary epidermolysis bullosa predisposes to development of autoimmune blistering disease.
Lehr S; Felber F; Tantcheva-Poór I; Keßler C; Eming R; Nyström A; Rizzi M; Kiritsi D
Front Immunol; 2022; 13():945176. PubMed ID: 35958577
[TBL] [Abstract][Full Text] [Related]
6. Proinflammatory Cytokines and Antiskin Autoantibodies in Patients With Inherited Epidermolysis Bullosa.
Annicchiarico G; Morgese MG; Esposito S; Lopalco G; Lattarulo M; Tampoia M; Bonamonte D; Brunetti L; Vitale A; Lapadula G; Cantarini L; Iannone F
Medicine (Baltimore); 2015 Oct; 94(42):e1528. PubMed ID: 26496255
[TBL] [Abstract][Full Text] [Related]
7. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.
Woodley DT; Cogan J; Hou Y; Lyu C; Marinkovich MP; Keene D; Chen M
J Clin Invest; 2017 Aug; 127(8):3028-3038. PubMed ID: 28691931
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and disease severity assessment of epidermolysis bullosa acquisita by ELISA for anti-type VII collagen autoantibodies: an Italian multicentre study.
Marzano AV; Cozzani E; Fanoni D; De Pità O; Vassallo C; Berti E; Parodi A; Crosti C; Cugno M
Br J Dermatol; 2013 Jan; 168(1):80-4. PubMed ID: 22913489
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions.
Kim JH; Kim YH; Kim S; Noh EB; Kim SE; Vorobyev A; Schmidt E; Zillikens D; Kim SC
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e224-30. PubMed ID: 22731917
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
11. Characterization of mutations of the type VII collagen gene (COL7A1) in recessive dystrophic epidermolysis bullosa mitis (M-RDEB) from three Korean patients.
Ryoo YW; Kim BC; Lee KS
J Dermatol Sci; 2001 Jun; 26(2):125-32. PubMed ID: 11378329
[TBL] [Abstract][Full Text] [Related]
12. Anti-Type VII Collagen Antibodies Are Identified in a Subpopulation of Bullous Pemphigoid Patients With Relapse.
Giusti D; Gatouillat G; Le Jan S; Plée J; Bernard P; Antonicelli F; Pham BN
Front Immunol; 2018; 9():570. PubMed ID: 29619029
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to extracellular collagen matrix components in epidermolysis bullosa and other bullous diseases.
Gay S; Fine JD; Storer JS
Arch Dermatol Res; 1988; 280(6):333-7. PubMed ID: 3056284
[TBL] [Abstract][Full Text] [Related]
14. Defining target antigens in linear IgA disease using skin from subjects with inherited epidermolysis bullosa as a substrate for indirect immunofluorescence microscopy.
Harman KE; Bhogal BS; Eady RA; McGrath JA; Black MM
Br J Dermatol; 1999 Sep; 141(3):475-80. PubMed ID: 10583051
[TBL] [Abstract][Full Text] [Related]
15. Immunofluorescence studies using skin sections of recessive dystrophic epidermolysis bullosa patients indicated that the antigen of anti-p200 pemphigoid is not a fragment of type VII collagen.
Liu Y; Shimizu H; Hashimoto T
J Dermatol Sci; 2003 Aug; 32(2):125-9. PubMed ID: 12850304
[TBL] [Abstract][Full Text] [Related]
16. Detection of anti-type VII collagen IgE antibodies in epidermolysis bullosa acquisita.
Koga H; Teye K; Yamashita K; Ishii N; Tsuruta D; Nakama T
Br J Dermatol; 2019 May; 180(5):1107-1113. PubMed ID: 30311191
[TBL] [Abstract][Full Text] [Related]
17. Epidermolysis bullosa: variability of expression of cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens in clinically uninvolved skin.
Fine JD
J Invest Dermatol; 1985 Jul; 85(1):47-9. PubMed ID: 3891876
[TBL] [Abstract][Full Text] [Related]
18. Mutations in PLOD3, encoding lysyl hydroxylase 3, cause a complex connective tissue disorder including recessive dystrophic epidermolysis bullosa-like blistering phenotype with abnormal anchoring fibrils and type VII collagen deficiency.
Vahidnezhad H; Youssefian L; Saeidian AH; Touati A; Pajouhanfar S; Baghdadi T; Shadmehri AA; Giunta C; Kraenzlin M; Syx D; Malfait F; Has C; Lwin SM; Karamzadeh R; Liu L; Guy A; Hamid M; Kariminejad A; Zeinali S; McGrath JA; Uitto J
Matrix Biol; 2019 Aug; 81():91-106. PubMed ID: 30463024
[TBL] [Abstract][Full Text] [Related]
19. Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa.
Siprashvili Z; Nguyen NT; Gorell ES; Loutit K; Khuu P; Furukawa LK; Lorenz HP; Leung TH; Keene DR; Rieger KE; Khavari P; Lane AT; Tang JY; Marinkovich MP
JAMA; 2016 Nov; 316(17):1808-1817. PubMed ID: 27802546
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of gentamicin 0.3% solution of oral erosions healing in patients with severe generalized recessive dystrophic epidermolysis bullosa and its impact on the expression of type VII collagen.
Osipowicz K; Wychowanski P; Nieckula P; Shamsa S; Wertheim-Tysarowska K; Wozniak K; Kowalewski C
Postepy Dermatol Alergol; 2021 Dec; 38(6):979-984. PubMed ID: 35126004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
